L-Thyroxine
(Synonyms: L-甲状腺素,Levothyroxine; T4) 目录号 : GC11268
L-Thyroxine是一种合成甲状腺激素,可模拟甲状腺分泌的天然甲状腺素,对调节新陈代谢、促进生长发育等起着关键作用。L-Thyroxine常用于治疗甲状腺功能减退症及其他甲状腺相关疾病。
Cas No.:51-48-9
Sample solution is provided at 25 µL, 10mM.
L-Thyroxine is a synthetic thyroid hormone that mimics the natural thyroxine secreted by the thyroid gland and plays a crucial role in regulating metabolism and promoting growth and development[1]. L-Thyroxine is commonly used to treat hypothyroidism and other thyroid-related diseases[2]. Additionally, L-Thyroxine is used in diagnostic tests for thyroid function[3] and has been shown to protect myocardial function[4].
In vitro, treatment of U2OS and MG63 osteoblast-like cells with L-Thyroxine (2.5–10μM) for 1 hour significantly increased the expression of Angiopoietin-1 (Ang1) in a dose-dependent manner. L-Thyroxine also significantly enhanced alkaline phosphatase (ALP) activity and cell mineralization capacity. Moreover, it significantly upregulated the expression of osteoblast-related protein markers, such as COL1A1, OC, BSP, Dlx5, Runx2, and OSX[5]. When human bronchial smooth muscle cells (ASM) were treated with L-Thyroxine (1–100nM) in combination with TGF-β1 (2ng/ml) for 28 hours, L-Thyroxine (100nM) significantly enhanced the proliferative response of ASM cells and reduced the expression of contractile proteins induced by TGF-β1 [6].
In vivo, L-Thyroxine (1μg/kg) was administered subcutaneously to mice, which were then exposed to gamma radiation (6Gy) or intraperitoneally injected with cisplatin (15mg/kg) to induce nephrotoxicity. L-Thyroxine significantly improved elevated renal function biomarkers, oxidative stress, and protected renal tissue from subsequent cellular damage[7]. In Ames dwarf mice, L-Thyroxine (0.1μg/g) in combination with growth hormone (GH, 6μg/g) was administered via subcutaneous injection twice a week starting at 2 weeks of age for 6 weeks. This treatment significantly promoted the growth of Ames dwarf mice[8].
References:
[1] Darbinyan L, Simonyan K, Hambardzumyan L, et al. Impact of L-thyroxine on hippocampal activity, morphology, and behavioral performance in thyroidectomized rats. Metab Brain Dis. 2025 Mar 10;40(3):140.
[2] McDermott MT. Hypothyroidism. Ann Intern Med. 2020 Jul 7;173(1):ITC1-ITC16.
[3] Fugazzola L, Persani L, Mannavola D, et al. Recombinant human TSH testing is a valuable tool for differential diagnosis of congenital hypothyroidism during L-thyroxine replacement. Clin Endocrinol (Oxf). 2003 Aug;59(2):230-6.
[4] Wang Y, Zhu S, Liu H, et al. Thyroxine Alleviates Energy Failure, Prevents Myocardial Cell Apoptosis, and Protects against Doxorubicin-Induced Cardiac Injury and Cardiac Dysfunction via the LKB1/AMPK/mTOR Axis in Mice. Dis Markers. 2019 Dec 16;2019:7420196.
[5] Park SH, Lee J, Kang MA, et al. Potential of l-thyroxine to differentiate osteoblast-like cells via Angiopoietin1. Biochem Biophys Res Commun. 2016 Sep 23;478(3):1409-15.
[6] Dekkers BG, Naeimi S, Bos IS, et al. L-thyroxine promotes a proliferative airway smooth muscle phenotype in the presence of TGF-β1. Am J Physiol Lung Cell Mol Physiol. 2015 Feb 1;308(3):L301-6.
[7] El-Hamoly T, El-Sharawy DM, El Refaye MS, et al. L-thyroxine modifies nephrotoxicity by regulating the apoptotic pathway: The possible role of CD38/ADP-ribosyl cyclase-mediated calcium mobilization. PLoS One. 2017 Sep 11;12(9):e0184157.
[8] Do A, Menon V, Zhi X, Gesing A, et al. Thyroxine modifies the effects of growth hormone in Ames dwarf mice. Aging (Albany NY). 2015 Apr;7(4):241-55.
L-Thyroxine是一种合成甲状腺激素,可模拟甲状腺分泌的天然甲状腺素,对调节新陈代谢、促进生长发育等起着关键作用[1]。L-Thyroxine常用于治疗甲状腺功能减退症及其他甲状腺相关疾病[2]。此外,L-Thyroxine也用于甲状腺功能的诊断检测[3],还具备保护心肌功能的作用[4]。
在体外,L-Thyroxine(2.5–10μM)处理U2OS和MG63成骨细胞样细胞1小时,可显著增加Angiopoietin-1(Ang1)的表达,并呈剂量依赖性;同时,L-Thyroxine显著提高碱性磷酸酶(ALP)活性,增强细胞矿化能力,此外,L-Thyroxine还显著上调了成骨相关蛋白标志物(如COL1A1、OC、BSP、Dlx5、Runx2和OSX)的表达[5]。L-Thyroxine(1–100nM)与TGF-β1(2ng/ml)联合处理处理人支气管平滑肌细胞(ASM)28小时,L-Thyroxine(100nM)显著增强ASM细胞的增殖反应,同时减少TGF-β1诱导的收缩蛋白的表达 [6]。
在体内,L-Thyroxine(1μg/kg)皮下注射预处理小鼠,随后暴露于γ射线(6Gy)或腹腔注射顺铂(15mg/kg)诱导肾毒性,L-Thyroxine显著改善了升高的肾功能生物标志物、氧化应激,并保护肾脏组织免受随后的细胞损伤[7]。L-Thyroxine(0.1μg/g)与生长激素(GH,6μg/g)联合治疗Ames dwarf mice,从2周龄开始,每周两次皮下注射,持续6周,用于处理Ames矮小鼠。L-Thyroxine显著促进了Ames dwarf mice的生长[8]。
Cell experiment [1]: | |
Cell lines | Human airway smooth muscle (ASM) cells |
Preparation Method | ASM cells were cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with streptomycin (50U/ml), penicillin (50µg/ml), and fetal bovine serum (10% vol/vol) at 37°C, 5% CO₂. Cells were serum-starved for 72 hours in serum-free DMEM supplemented with streptomycin, penicillin, and 1% ITS (insulin, transferrin, selenium) before treatment. Cell treated with L-Thyroxine (T4) at 100nM in combination with TGF-β1 (2ng/ml) for 28 hours. |
Reaction Conditions | 100nM; 28h |
Applications | L-Thyroxine significantly increased ASM cell proliferation in the presence of TGF-β1. L-Thyroxine also decreased the expression of contractile proteins (smooth muscle α-actin and calponin) in TGF-β1-treated cultures. |
Animal experiment [1]: | |
Animal models | Ames dwarf (df/df) mice |
Preparation Method | Juvenile Ames dwarf mice (both male and female) were treated with a combination of growth hormone (GH, 6μg/g body weight) and L-Thyroxine (0.1μg/g body weight) via subcutaneous injections. GH was administered twice daily, while L-Thyroxine was given three times per week. The treatment started at 2 weeks of age and continued for 6 weeks. |
Dosage form | 0.1μg/g body weight; subcutaneous injections |
Applications | The combination treatment with GH and L-Thyroxine significantly increased body weight in Ames dwarf mice. GH + L-Thyroxine treatment reduced the expression of genes such as insulin receptor (IR), insulin receptor substrate-1 (IRS-1), phosphoinositide 3-kinase (PI3K), and GLUT4 in these tissues, compared to GH alone. |
References: |
Cas No. | 51-48-9 | SDF | |
别名 | L-甲状腺素,Levothyroxine; T4 | ||
化学名 | (2S)-2-amino-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]propanoic acid | ||
Canonical SMILES | C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N | ||
分子式 | C15H11I4NO4 | 分子量 | 776.87 |
溶解度 | ≥ 27.35mg/mL in DMSO | 储存条件 | Store at 2-8°C |
General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 |
制备储备液 | |||
![]() |
1 mg | 5 mg | 10 mg |
1 mM | 1.2872 mL | 6.4361 mL | 12.8722 mL |
5 mM | 0.2574 mL | 1.2872 mL | 2.5744 mL |
10 mM | 0.1287 mL | 0.6436 mL | 1.2872 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet